Search

everythinglearnresearchcommunity

for

Search:↓

Ginkgo biloba has health benefits but also contains toxic compounds, driving interest in its use in medicine and food.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

New compounds show promise as nonsteroidal treatments for hair loss.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

A girl with a rare genetic disorder had a unique bone condition, highlighting the need for careful diagnosis and suggesting the disorder might be more common than thought.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Indometacin was chosen for a gel to help treat mastopathy and prevent breast cancer.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.